Financial Data and Key Metrics Changes - Cash NOI for Q1 2025 was $41.2 million, a slight increase from $41 million in Q4 2024, driven by contractual lease escalations and a recent acquisition [12] - AFFO for Q1 2025 was $29.4 million or $0.53 per diluted share, down from $30.2 million or $0.54 per diluted share in Q4 2024, primarily due to increased interest expenses [13] - AFFO decreased 23.1% compared to Q1 2024, largely due to nonrecurring fees and bankruptcies impacting cash NOI [14] Business Line Data and Key Metrics Changes - The weighted average remaining lease term is over 9.5 years with average annual contractual rent escalations of 2.2%, providing predictable long-term revenues [9] - The company maintained a 96% lease rate, unchanged from the previous quarter [23] Market Data and Key Metrics Changes - The company completed two acquisitions totaling approximately $59 million in March and April 2025, expanding its footprint into Tennessee and Delaware [19] - The Knoxville Healthcare facility is fully leased to a joint venture with investment-grade rated partners, while the Dover facility is also fully leased to a similar joint venture [20] Company Strategy and Development Direction - The company focuses on acquiring health care properties, which are seen as essential and non-discretionary, providing a stable investment opportunity [7] - The management emphasizes a disciplined investment approach, navigating macroeconomic uncertainties while seeking accretive acquisitions [21] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the current economic challenges, including inflation and potential recession, but believes the company's focus on health care properties positions it well for long-term success [6][11] - The demographic shift towards an aging population is expected to drive increased health care spending, benefiting the company's portfolio [10] Other Important Information - The company has over $598 million in liquidity available for future acquisitions, supported by a new $600 million revolving line of credit [16][17] - The credit loss reserve increased by $171,000, related to the company's mezzanine loans, reflecting a qualitative assessment under GAAP [31][32] Q&A Session Summary Question: Update on Stoughton property - Management engaged a broker to solicit bids for the sale or lease of the Stoughton property, with more interest in sales for multifamily use, potentially involving demolition and entitlement processes [27][29] Question: Update on mezzanine loan investments - The company has funded amounts related to the mezzanine loan for the inpatient rehab facility and expects both loans to be fully funded by Q3 2025 [30] Question: Impact of credit loss reserve - The credit loss reserve is a required GAAP reserve for loans receivable, assessed qualitatively each quarter, and is related to the two mezzanine loans [31][32] Question: Investment pipeline and cost of equity - The company sees opportunities to acquire between $150 million and $250 million of real estate under normal conditions, but is cautious due to current market uncertainties [35][38] Question: Minimum yield for acquisitions - The company targets a cap rate of 6.5% to 7.5% for quality acquisitions, depending on property type and sponsorship quality [42] Question: Improvement in EBITDARM coverage - The improvement in EBITDARM coverage was driven by properties moving up in coverage levels, with a significant portion of the affected ABR being investment-grade rated [44][46] Question: Borrowing costs for future debt - Current borrowing on the revolving line of credit is at 5.57%, with plans to explore longer-duration fixed-rate debt in the future [48][50]

Financial Data and Key Metrics Changes - Cash NOI for Q1 2025 was $41.2 million, a slight increase from $41 million in Q4 2024, representing a 0.5% increase driven by scheduled lease escalations and a recent acquisition [11] - AFFO for Q1 2025 was $29.4 million or $0.53 per diluted share, down from $30.2 million or $0.54 per diluted share in Q4 2024, reflecting a 2.6% decrease primarily due to increased interest expenses [12] - Compared to Q1 2024, AFFO decreased by 23.1%, largely due to nonrecurring fees and bankruptcies impacting cash NOI [12] Business Line Data and Key Metrics Changes - The company maintained a weighted average remaining lease term of over 9.5 years with average annual contractual rent escalations of 2.2%, indicating stable long-term revenue growth [8][22] - The portfolio consisted of approximately 5.3 million rentable square feet, with a leasing rate of 96%, unchanged from the previous quarter [22] Market Data and Key Metrics Changes - The company reported that 73.3% of ABR from tenants with financial reporting maintained a strong EBITDARM coverage ratio of 5.3 times, indicating financial stability among tenants [16] - The percentage of ABR with EBITDARM coverage below one times decreased significantly from 1.8% to 0.5%, driven by improvements in tenant coverage levels [43] Company Strategy and Development Direction - The company focuses on acquiring health care properties, which are seen as essential and non-discretionary, providing a stable investment opportunity amid economic uncertainty [7] - Recent acquisitions included two healthcare facilities totaling approximately $59 million, expanding the company's footprint into new states and aligning with its strategic focus on necessity-based healthcare properties [18][19] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the current economic challenges, including inflation and potential recession, but expressed confidence in the company's ability to navigate these issues due to its strong financial position and focus on healthcare real estate [6][10] - The demographic shift towards an aging population is expected to drive increased healthcare spending, benefiting the company's portfolio and future acquisition opportunities [9][10] Other Important Information - The company has over $598 million in liquidity available for future acquisitions, supported by a new $600 million revolving line of credit [15] - The company is currently evaluating the financial strength of its tenant base and monitoring potential impacts from tariffs and healthcare policy changes [17] Q&A Session Summary Question: Update on Stoughton property status - Management engaged a broker to solicit bids for the sale or lease of the Stoughton property, with more interest from multifamily developers, potentially involving demolition and entitlement processes [26][28] Question: Update on mezzanine loan investments - The company has funded amounts related to the mezzanine loan for the inpatient rehab facility and expects both loans to be fully funded by Q3 2025 [30] Question: Increase in credit loss reserve - The increase in the credit loss reserve is a required GAAP reserve related to loans receivable, assessed quarterly based on qualitative judgments [31][32] Question: Impact of stock price on acquisition pace - The company is cautious about leveraging to the high end of its target range until its stock price recovers, indicating a methodical approach to acquisitions [37] Question: Minimum yield for quality acquisitions - The company is currently looking for opportunities in the 6.5% to 7.5% cap rate range, depending on property type and quality [41][42] Question: Improvement in EBITDARM coverage - The improvement in EBITDARM coverage was due to properties moving up in coverage levels, with a significant portion of the lower coverage associated with investment-grade rated tenants [43][44]

Core Insights - Aedifica reported strong operational performance with results exceeding budget expectations [2] - The real estate portfolio is valued at over €6.1 billion as of March 31, 2025 [3] - The company maintains a debt-to-assets ratio below 40% and has strong liquidity [4] - The outlook for 2025 remains positive and on track [5] Financial Performance - EPRA Earnings amounted to €62.6 million, reflecting a 5% increase compared to March 31, 2024, equating to €1.32 per share [7] - Rental income rose to €93.0 million, marking a 13% increase from the same period last year [7] - There was a 3.2% increase in rental income on a like-for-like basis in the first quarter [7] - The weighted average unexpired lease term is 18 years, with an occupancy rate of 100% [7] Portfolio and Asset Management - The company operates 607 healthcare properties serving nearly 48,300 end users across 7 countries [7] - A total of 30 properties, including the entire portfolio in Sweden, were divested for approximately €100 million as part of a strategic asset rotation program [7] - The valuation of marketable investment properties increased by 0.25% on a like-for-like basis in Q1 [7] Investment and Financing - An investment program of €126 million is underway for pre-let development projects, with €66 million remaining to be invested [7] - In the first quarter, 3 projects from the committed pipeline were delivered with a total investment budget of approximately €45.5 million, while 2 new projects were added [7] - The debt-to-assets ratio was 39.9% as of March 31, 2025, and reduced to 39.5% after accounting for cash from disposals [7] - The company has over €800 million of headroom on committed credit lines and cash available for CAPEX and liquidity needs [7] - The average cost of debt, including commitment fees, is 2.2% [7] - A BBB investment-grade credit rating with a stable outlook has been assigned by S&P [7] Shareholder Returns - The EPRA NTA increased to €77.86 per share compared to €76.63 per share as of December 31, 2024 [7] - The proposed dividend for the 2025 financial year is €4.00 per share (gross), representing a pay-out ratio of 80% of consolidated EPRA Earnings [7]